The FCTC COP10 Agenda and supporting documents: implications for the future of tobacco harm reduction Our latest Briefing Paper looks ahead to the upcoming COP10 meeting in Panama and assesses what the Agenda could mean for the future availability of the safer nicotine products that underpin tobacco harm reduction.
A survey of available research published by the peer-reviewed journal ACS Omega last year claimed that herbal cigarettes that contain ingredients like mugwort, coltsfoot, and damiana increase smokers' risk of "numerous chronic metabolic diseases, including heart disease, stroke, and type 2 diabetes." Basically, the study says, we should assume burning any herb and putting it into our lungs "may affect the human body in many ways and cause serious diseases." Murphy seems to be acutely aware of the risks, as he recently swore off playing another smoker anytime soon, even when the cigarettes used on set are non-nicotine
There are insufficient data regarding obstetrical safety of parenteral lorazepam, including use in cesarean section
Health effects include lung cancer, respiratory illness, low birth-weight (among infants whose mothers smoked hookah during pregnancy) and periodontal disease